Press release 14 2018 - OMCLs discuss Brexit and updates to medicines’ testing methods at annual meeting - May 2018
The Annual Meeting of the Official Medicines Control Laboratories (OMCLs) took place on 14-18 May in Sarajevo (Bosnia and Herzegovina). It was attended by 230 participants from 38 countries, representing 65 official laboratories and including a representative of the OMCL Network, the Taiwan Food and Drug Administration, which just joined the Network as an associated member. Representatives from Canada, Israel, the Russian Federation and Singapore also attended the event, which was jointly organised by the EDQM and the Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina (ALMBiH).
Press Release - European and Indian Pharmacopoeias to cooperate further on provision of strong quality standards for medicines - May 2018
The EDQM/European Pharmacopoeia (Ph. Eur.) and the Indian Pharmacopoeia Commission (IPC) held a symposium on the quality control of medicines in the context of the pharmaceutical legislation and regulatory requirements that exist in Europe and India.
Press Release - Pharmacopoeial Discussion Group (PDG) holds first videoconference meeting - May 2018
The Pharmacopoeial Discussion Group (PDG), consisting of representatives from the European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), the United States Pharmacopoeia (USP) and the WHO (International Pharmacopoeia) as observer, held its first interim videoconference on Wednesday 11 April 2018.
Press release - Committee on organ transplantation at Council of Europe warns against Global Kidney Exchange programmes - April 2018
The Council of Europe Committee on Organ Transplantation (CD-P-TO), with the support of the Council of Europe Committee on Bioethics (DH-BIO), has issued a recommendation to the Member States of the Council of Europe, as well as health authorities, hospitals and professionals not to engage in Global Kidney Exchange (GKE) programmes and hence not to consider the inclusion of “financially incompatible” donor-recipient pairs in any kidney exchange programme.
Press Release - Ph. Eur. - Live Biotherapeutic Products (LBPs): unprecedented quality requirements by the Ph. Eur. Commission - April 2018
At its 160th Session, the European Pharmacopoeia (Ph. Eur.) Commission achieved an important milestone in the setting of quality requirements for Live Biotherapeutic Products (LBPs) with the adoption of quality standards for LBPs for human use: a general monograph on Live biotherapeutic products for human use (3053), as well as two general chapters: Microbial examination of live biotherapeutic products (LBP): test for enumeration of microbial contaminants (2.6.36) and Microbiological examination of live biotherapeutic products: test for specified microorganism (2.6.38).
Press Release - Ph. Eur. - Infrared Absorption Spectrophotometry - April 2018
At its 160th session (March 2018) the Ph. Eur. Commission adopted a new version of one of its major general methods, which has undergone extensive revision. The chapter on Infrared Absorption Spectrophotometry (2.2.24) is one of the original cornerstones of pharmacopoeial testing, referenced in many general texts and more than 1200 individual monographs.
Press Release - Ph. Eur. - Outcome of the 160th Session of the European Pharmacopoeia Commission - April 2018
At its 160th Session which took place in Strasbourg on 20-21 March 2018, the European Pharmacopoeia (Ph. Eur.) Commission adopted 19 new monographs, 3 new chapters, 51 revised monographs and 15 revised chapters,
Press Release - EDQM issues Automated Dose Dispensing (ADD) Guidelines - March 2018
The EDQM has issued its Guidelines on ‘Best Practice for the Automated Dose Dispensing (ADD) Process and Care and Safety of Patients’. These Guidelines take into consideration the diversity of practices across Europe, and aim to ensure that ADD care is provided to a consistently high standard, and that medicines continue to be supplied safely to patients.
Press Releases 2017 - Archive
Access all of the press releases published by the EDQM in 2017.
Press Release - EDQM rolls out reference standards for elemental impurities: lead, cadmium, mercury and arsenic - February 2018
The European Directorate for the Quality of Medicines and Healthcare (EDQM) announces the availability of four new elemental impurity chemical reference standards (CRS) in its European Pharmacopoeia catalogue: lead solution CRS, cadmium solution CRS, mercury solution CRS and arsenic solution CRS. These elements occurring in nature are amongst the greatest potential sources of elemental contamination in medicinal products and substances for pharmaceutical use; the new reference standards underpin the European Pharmacopoeia (Ph.Eur.) chapter describing the determination of elemental impurities (2.4.20).